Kosaka K, Kuzuya T, Akanuma Y, Hagura R
Diabetologia. 1980 Jan;18(1):23-8. doi: 10.1007/BF01228297.
The changes in insulin response to a 100 g glucose tolerance test after treatment by diet, sulphonylurea and insulin were compared in non-ketotic diabetic patients who had fasting blood glucose concentrations higher than 160 mg/100 ml. Patients were selected so that their pre-treatment and post-treatment blood glucose levels were comparable between different treatment groups. Their insulin responses were poor initially but increased significantly when the diabetic state was improved by each treatment. The degree of improvement of insulin response was similar between different treatment groups, when their fasting blood glucose decreased below 140 mg/100 ml and the glucose tolerance curves were improved to a similar extent. Pre- and post-treatment sigma IRI values (sum of insulin values during glucose tolerance test, mean +/- SD) were 102 +/- 50 and 200 +/- 37 microU/ml in diet-treated group (n = 28), 90 +/- 40 and 195 +/- 53 microU/ml in sulphonylurea-treated group (n = 48), and 83 +/- 28 and 193 +/- 38 microU/ml in insulin-treated group (n = 13), respectively. The data suggest that the poor insulin response in overt diabetes results not only from an inherent insensitivity of B-cells to glucose but also from the metabolic derangement of diabetes. Poor insulin response and overtly diabetic metabolism seems to form a vicious cycle.
对空腹血糖浓度高于160mg/100ml的非酮症糖尿病患者,比较了饮食、磺脲类药物及胰岛素治疗后其对100g葡萄糖耐量试验的胰岛素反应变化。选择患者时确保不同治疗组之间其治疗前和治疗后的血糖水平具有可比性。他们的胰岛素反应最初较差,但每种治疗使糖尿病状态改善时,胰岛素反应显著增加。当空腹血糖降至140mg/100ml以下且葡萄糖耐量曲线改善程度相似时,不同治疗组之间胰岛素反应的改善程度相似。饮食治疗组(n = 28)治疗前和治疗后的σIRI值(葡萄糖耐量试验期间胰岛素值总和,均值±标准差)分别为102±50和200±37μU/ml,磺脲类药物治疗组(n = 48)分别为90±40和195±53μU/ml,胰岛素治疗组(n = 13)分别为83±28和193±38μU/ml。数据表明,显性糖尿病中胰岛素反应差不仅源于β细胞对葡萄糖固有的不敏感性,还源于糖尿病的代谢紊乱。胰岛素反应差和显性糖尿病代谢似乎形成恶性循环。